IN2014DN11044A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN11044A IN2014DN11044A IN11044DEN2014A IN2014DN11044A IN 2014DN11044 A IN2014DN11044 A IN 2014DN11044A IN 11044DEN2014 A IN11044DEN2014 A IN 11044DEN2014A IN 2014DN11044 A IN2014DN11044 A IN 2014DN11044A
- Authority
- IN
- India
- Prior art keywords
- granules
- fenofibrate
- vivo
- surfactant
- weight
- Prior art date
Links
- 239000008187 granular material Substances 0.000 abstract 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 4
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 abstract 3
- 229960002297 fenofibrate Drugs 0.000 abstract 3
- 229920002678 cellulose Polymers 0.000 abstract 2
- 239000001913 cellulose Substances 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2012/043971 WO2014003706A1 (en) | 2012-06-25 | 2012-06-25 | Fenofibrate formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN11044A true IN2014DN11044A (es) | 2015-09-25 |
Family
ID=49783663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN11044DEN2014 IN2014DN11044A (es) | 2012-06-25 | 2012-06-25 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2863890A4 (es) |
BR (1) | BR112014032579A2 (es) |
CA (1) | CA2877901A1 (es) |
IN (1) | IN2014DN11044A (es) |
WO (1) | WO2014003706A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101925590B1 (ko) * | 2016-08-30 | 2018-12-05 | 대원제약 주식회사 | 개선된 생체이용률을 갖는 페노피브릭산 제제 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2627696B1 (fr) | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
US7863331B2 (en) * | 1999-07-09 | 2011-01-04 | Ethypharm | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
US8586094B2 (en) * | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
US20080241070A1 (en) * | 2000-09-21 | 2008-10-02 | Elan Pharma International Ltd. | Fenofibrate dosage forms |
EP1853249A2 (en) * | 2005-02-10 | 2007-11-14 | LifeCycle Pharma A/S | A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor |
US20090252787A1 (en) | 2006-07-28 | 2009-10-08 | Dr. Reddy's Laboratories Ltd. | Granular pharmaceutical compositions |
FR2940118B1 (fr) | 2008-12-24 | 2013-08-09 | Ethypharm Sa | Formulation pharmaceutique de fenofibrate nanonise |
US20100166857A1 (en) | 2008-12-30 | 2010-07-01 | Dong Yan | Pharmaceutical dosage forms and methods of manufacturing same |
US20110217369A1 (en) | 2009-09-03 | 2011-09-08 | Ranbaxy Laboratories Limited | Fenofibrate compositions |
-
2012
- 2012-06-25 IN IN11044DEN2014 patent/IN2014DN11044A/en unknown
- 2012-06-25 BR BR112014032579A patent/BR112014032579A2/pt not_active Application Discontinuation
- 2012-06-25 EP EP12880074.5A patent/EP2863890A4/en active Pending
- 2012-06-25 WO PCT/US2012/043971 patent/WO2014003706A1/en active Application Filing
- 2012-06-25 CA CA2877901A patent/CA2877901A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2863890A1 (en) | 2015-04-29 |
EP2863890A4 (en) | 2015-12-09 |
WO2014003706A1 (en) | 2014-01-03 |
BR112014032579A2 (pt) | 2017-06-27 |
CA2877901A1 (en) | 2014-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ603151A (en) | N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives | |
MX368779B (es) | Fertilizantes con polímeros polianiónicos y método para aplicar polímeros polianiónicos a plantas. | |
MX2015008100A (es) | Composiciones que comprenden un compuesto de triazol. | |
NZ628294A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
AU348189S (en) | Hitch ball mount | |
MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
GB2492674A (en) | Fibrous structures | |
WO2013175221A3 (en) | Composition | |
GB2499479A (en) | Stabilisation of viral particles | |
PL2768936T3 (pl) | Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie | |
MX340983B (es) | Composiciones farmaceuticas y nutraceuticas de acido abscisico. | |
MX342947B (es) | Tratamiento de diabetes tipo 2. | |
PH12014502512A1 (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
MX2015003074A (es) | Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas. | |
WO2013058774A8 (en) | Compositions comprising ascorbic acid and an imaging agent and related methods | |
MY181656A (en) | Glue composition | |
MX339063B (es) | Composiciones para suministrar perfume a la piel. | |
NZ628451A (en) | Dehydrated plant-derived products and methods for making the same | |
MX2013004878A (es) | N-hetarilmetil pirazolilcarboxamidas. | |
MX345022B (es) | Composiciones de manteca. | |
IN2014DN11044A (es) | ||
WO2011156045A3 (en) | Tablet formulation of ezatiostat | |
MX344396B (es) | Poliesteres de sacarosa. | |
HUE065064T2 (hu) | HMB-t éa ATP-t tartalmazó készítmények és felhasználásuk | |
FR2981067B1 (fr) | Procede de preparation du 1,2,3-trimethoxypropane, utilisations et compositions comprenant ledit 1,2,3-trimethoxypropane |